Amend CSHB 1 (house committee printing) as follows:

In Article II of the bill, following the appropriations to the Health and Human Services Commission (page II-33), add the following appropriately numbered amendment:

____.  DRUG SHORTAGE REQUIREMENTS RELATING TO THE PREFERRED DRUG LIST. To address potential access to pharmaceutical products on the Health and Human Services (HHSC) preferred drug list during a drug shortage, the Health and Human Services must:

(1)  Consult the annual reports, on-line drug shortage and manufacturer compliance letters available through the U.S. Food and Drug Administration's (FDA) Center for Biologics and Research (CBER) and the Center for Drug Evaluation and Research (CDER) prior to HHSC's Drug Utilization Review (DUR)committee's review of a drug therapeutic class to monitor, identify, or mitigate any anticipated drug shortages;

(2)  Ensure the DUR is reviewing FDA drug shortage resources and the impact on preferred drug list product availability during their quarterly meeting; and

(3)  Develop a process to dispense and approve a comparable non-preferred drug in place of a preferred prescription drug identified by HHSC as being in drug shortage.